The test may be able to personalise chemotherapy, preventing patients from potentially going through the harsh treatment for ...

Watch the “What This Means" segment here HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ( ...

Over a median follow-up of 7 years, breast cancer survivors had an 8% lower risk of Alzheimer's dementia compared with ...

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer ...

Tens of thousands of cancer patients going through gruelling chemotherapy could have DNA test to predict which form of the ...

Oncologists vary widely in treating DLBCL with cardiomyopathy, often diverging from guidelines due to limited evidence on ...

Research led by Samsung Medical Center finds breast cancer survivors exhibit an 8% lower risk of Alzheimer's dementia (AD) ...

Chemotherapy seeks to destroy tumor cells and has been a standard treatment for cancer for decades. However, it doesn't ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

CNS Pharmaceuticals (NASDAQ: CNSP) announced the release of a Virtual Investor KOL Connect segment featuring Dr. Erin Dunbar, Director of Neuro-Oncol ...